Javascript must be enabled to continue!
The Inhibitory Fc[gamma] Receptor is Unnecessary for IVIG Efficacy
View through CrossRef
AbstractIntravenous gamma globulin (IVIG) is used as an effective therapy for many different autoimmune and inflammatory diseases. The current paradigm for the mechanism underpinning anti-inflammatory effects links IVIG administration to increased expression and activity of the inhibitory Fc[gamma] receptor (Fc[gamma]RIIB) on splenic macrophages. This hypothesis has been disputed in the literature. Here we show that IVIG administered in the context of passive antibody-mediated thrombocytopenia to be therapeutically efficacious in both splenectomized and unmanipulated Balb/c mice despite no upregulation of Fc[gamma]RIIB mRNA in the spleen. Moreover, IVIG effectively ameliorated immune thrombocytopenia (ITP) in Fc[gamma]RIIB-deficient Balb/c mice, but not in Fc[gamma]RIIB-/- or Fc[gamma]RIIB+/+ control mice with a C57BL6/129S background. Our results demonstrate that Fc[gamma]RIIB is not relevant to the beneficial effects of IVIG. We anticipate that investigators will now shift their research focus away from Fc[gamma]RIIB and seek out other possible mechanism(s) to explain the plethora of diseases and conditions treatable with IVIG.
Springer Science and Business Media LLC
Title: The Inhibitory Fc[gamma] Receptor is Unnecessary for IVIG Efficacy
Description:
AbstractIntravenous gamma globulin (IVIG) is used as an effective therapy for many different autoimmune and inflammatory diseases.
The current paradigm for the mechanism underpinning anti-inflammatory effects links IVIG administration to increased expression and activity of the inhibitory Fc[gamma] receptor (Fc[gamma]RIIB) on splenic macrophages.
This hypothesis has been disputed in the literature.
Here we show that IVIG administered in the context of passive antibody-mediated thrombocytopenia to be therapeutically efficacious in both splenectomized and unmanipulated Balb/c mice despite no upregulation of Fc[gamma]RIIB mRNA in the spleen.
Moreover, IVIG effectively ameliorated immune thrombocytopenia (ITP) in Fc[gamma]RIIB-deficient Balb/c mice, but not in Fc[gamma]RIIB-/- or Fc[gamma]RIIB+/+ control mice with a C57BL6/129S background.
Our results demonstrate that Fc[gamma]RIIB is not relevant to the beneficial effects of IVIG.
We anticipate that investigators will now shift their research focus away from Fc[gamma]RIIB and seek out other possible mechanism(s) to explain the plethora of diseases and conditions treatable with IVIG.
Related Results
On Proximal Relations in Transformation Semigroups Arising from Generalized Shifts
On Proximal Relations in Transformation Semigroups Arising from Generalized Shifts
For a finite discrete topological space $X$ with at least two elements, a nonempty set $\Gamma$, and a map $\varphi:\Gamma \to \Gamma$, $\sigma_{\varphi}:X^{\Gamma} \to X^{\Gamma}$...
Low-Dose Methylprednisolone Therapy for Intravenous Immunoglobulin-Resistant Kawasaki Disease
Low-Dose Methylprednisolone Therapy for Intravenous Immunoglobulin-Resistant Kawasaki Disease
Abstract
Background The dose of methylprednisolone therapy for intravenous immunoglobulin-resistant Kawasaki disease (IVIG-resistant KD) remains controversial. The study ai...
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Abstract 125: Steroid Treatment in the Acute Phase of Kawasaki Disease in Mexican Children. Are they Useful?
Abstract 125: Steroid Treatment in the Acute Phase of Kawasaki Disease in Mexican Children. Are they Useful?
Background:
Intravenous immunoglobulin (IVIG) and aspirin is the standard initial therapy in the treatment of Kawasaki disease (KD), which is proven to decrease the inc...
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance
The mechanism of effect of high-dose intravenous immunoglobulin (IVIG) therapy in immune cytopenias is incompletely known. One of the leading theories ascribes the short-term effec...
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance
High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance
Abstract
The mechanism of effect of high-dose intravenous immunoglobulin (IVIG) therapy in immune cytopenias is incompletely known. One of the leading theories ascri...
A review of the adverse effects of intravenous immunoglobulin infusion in pediatric multisystem inflammatory disease patients (MIS-C)
A review of the adverse effects of intravenous immunoglobulin infusion in pediatric multisystem inflammatory disease patients (MIS-C)
Abstract
Background
Multisystem inflammatory syndrome in children (MIS-C) are associated with systemic inflammation and intravenous immunoglobulin (IVIG) infusion is the f...
Factors associated with liver injury after intravenous gamma globulin treatment in children with Kawasaki disease
Factors associated with liver injury after intravenous gamma globulin treatment in children with Kawasaki disease
Abstract
Background: The etiology of liver injury in children with Kawasaki disease(KD) is not yet clear.It is common for children who are responded to intravenous gamma gl...

